- lead to
strokes and death. Ryan DH (September 2021). "Next
Generation Antiobesity Medications: Setmelanotide, Semaglutide,
Tirzepatide and Bimagrumab:...
- (also
known as SR141716;
trade names Acomplia, Zimulti) is an
anorectic antiobesity drug
approved in
Europe in 2006 but was
withdrawn worldwide in 2008 due...
- (November 2016). "Beta3-adrenoreceptor
agonist mirabegron - a
potential antiobesity drug?".
Expert Opinion on Pharmacotherapy. 17 (16): 2125–2127. doi:10...
- ATC code A08
Antiobesity preparations,
excluding diet
products is a
therapeutic subgroup of the
Anatomical Therapeutic Chemical classification System...
- regenerative, neuroprotective, anti-atherosclerotic, antitumor, antiangiogenic,
antiobesity, and
anxiolytic properties.
Phase I
clinical trials of trodusquemine...
- PMID 33030356. S2CID 222213936. Ryan DH (September 2021). "Next
Generation Antiobesity Medications: Setmelanotide, Semaglutide,
Tirzepatide and Bimagrumab:...
- 1093/ajhp/zxae105. PMID 38656319. "U.S.
Leads the
world in list
prices for diabetes,
antiobesity meds". 21
August 2023.
Archived from the
original on 20
January 2024...
- Antidiarrheals,
intestinal anti-inflammatory/anti-infective
agents A08
Antiobesity preparations,
excluding diet
products A09 Digestives,
including enzymes...
- (2005-07-01). "Fucoxanthin from
edible seaweed,
Undaria pinnatifida,
shows antiobesity effect through UCP1
expression in
white adipose tissues". Biochemical...
-
Lipase inhibitors belong to a drug
class that is used as an
antiobesity agent.
Their mode of
action is to
inhibit gastric and
pancreatic lipases, enzymes...
